These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32921093)

  • 41. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study.
    Gomila A; Carratalà J; Eliakim-Raz N; Shaw E; Tebé C; Wolkewitz M; Wiegand I; Grier S; Vank C; Cuperus N; Van den Heuvel L; Vuong C; MacGowan A; Leibovici L; Addy I; Pujol M;
    Antimicrob Resist Infect Control; 2019; 8():198. PubMed ID: 31827779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center.
    Filozov A; Visintainer P; Carbonaro C; Aguero-Rosenfeld M; Wormser GP; Montecalvo MA
    Am J Infect Control; 2009 Nov; 37(9):723-8. PubMed ID: 19501935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates.
    Ranjan Dash N; Albataineh MT; Alhourani N; Khoudeir AM; Ghanim M; Wasim M; Mahmoud I
    Travel Med Infect Dis; 2018; 22():46-50. PubMed ID: 29409967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome.
    Tumbarello M; Spanu T; Sanguinetti M; Citton R; Montuori E; Leone F; Fadda G; Cauda R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):498-504. PubMed ID: 16436702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-associated urinary infections requiring hospitalization: risk factors, microbiological characteristics and patterns of antibiotic resistance.
    Medina-Polo J; Guerrero-Ramos F; Pérez-Cadavid S; Arrébola-Pajares A; Sopeña-Sutil R; Benítez-Sala R; Jiménez-Alcaide E; García-González L; Alonso-Isa M; Lara-Isla A; Passas-Martínez JB; Tejido-Sánchez Á
    Actas Urol Esp; 2015 Mar; 39(2):104-11. PubMed ID: 25301702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
    Kung CH; Ku WW; Lee CH; Fung CP; Kuo SC; Chen TL; Lee YT
    J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance of catheter-associated urinary tract infection in 4 intensive care units at Alexandria university hospitals in Egypt.
    Talaat M; Hafez S; Saied T; Elfeky R; El-Shoubary W; Pimentel G
    Am J Infect Control; 2010 Apr; 38(3):222-8. PubMed ID: 19837480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant
    Sendra E; López Montesinos I; Rodriguez-Alarcón A; Du J; Siverio-Parés A; Arenas-Miras M; Cañas-Ruano E; Prim N; Durán-Jordà X; Blasco-Hernando F; García-Alzorriz E; Cots F; Ferrández O; Gómez-Zorrilla S
    Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Yilmaz E; Akalin H; Ozbey S; Kordan Y; Sinirtaş M; Gürcüoglu E; Ozakin C; Heper Y; Mistik R; Helvaci S
    J Chemother; 2008 Oct; 20(5):581-5. PubMed ID: 19028620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study.
    Demirdag K; Hosoglu S
    J Infect Dev Ctries; 2010 Nov; 4(11):717-22. PubMed ID: 21252449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catheter-associated urinary tract infection in a surgical intensive care unit.
    Mladenović J; Veljović M; Udovicić I; Lazić S; Segrt Z; Ristić P; Suljagić V
    Vojnosanit Pregl; 2015 Oct; 72(10):883-8. PubMed ID: 26665554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.
    Thaden JT; Fowler VG; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):49-54. PubMed ID: 26458226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants.
    Kim YH; Yang EM; Kim CJ
    J Pediatr (Rio J); 2017; 93(3):260-266. PubMed ID: 27842212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
    Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
    Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features and molecular epidemiology of plasmid-mediated DHA-type AmpC β-lactamase-producing Klebsiella pneumoniae blood culture isolates, Hong Kong.
    Luk S; Wong WK; Ho AY; Yu KC; To WK; Ng TK
    J Glob Antimicrob Resist; 2016 Dec; 7():37-42. PubMed ID: 27568104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.
    Behar PR; Teixeira PJ; Fachel JM; Kalil AC
    J Hosp Infect; 2008 Feb; 68(2):123-9. PubMed ID: 18192077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Park SY; Kang CI; Joo EJ; Ha YE; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: results based on a retrospective study from a tertiary hospital.
    Ma KL; Wang CX
    Am J Infect Control; 2013 Jul; 41(7):601-6. PubMed ID: 23352074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.